Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 00378-5440
Product NDC
00378-5440- Manufacturer
- Mylan Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 27, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA208452
Need to source Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Emtricitabine | 200 mg/1 |
| Rilpivirine Hydrochloride | 25 mg/1 |
| Tenofovir Disoproxil Fumarate | 300 mg/1 |
Drug Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Packaging Options(1)
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5440-93)
External Resources